Protease-activated receptor-1 (PAR1) is a G-protein-coupled receptor uniquely activated by proteolysis. Thrombin, a coagulant protease, induces inflammatory responses and endothelial barrier permeability through the activation of PAR 1. Activated protein C (APC), an anti-coagulant protease, also activates PAR 1. However, unlike thrombin, APC elicits anti-inflammatory responses and protects against endothelial barrier dysfunction induced by thrombin. We found that thrombin and APC signaling were lost in PAR 1-deficient endothelial cells, indicating that PAR 1 is the major effector of protease signaling. To delineate the mechanism responsible for protease-selective signaling by PAR 1, we examined the effect of APC and thrombin on the activation of RhoA and Rac1, small GTPases that differentially regulate endothelial barrier permeability. Thrombin caused robust RhoA signaling but not Rac1 activation, whereas APC stimulated a marked increase in Rac1 activation but not RhoA signaling, consistent with the opposing functions of these proteases on endothelial barrier integrity. Strikingly, APC signaling and endothelial barrier protection effects were abolished in cells lacking caveolin-1, whereas thrombin signaling remained intact. These findings suggest that compartmentalization of PAR 1 in caveolae is critical for APC selective signaling to Rac1 activation and endothelial barrier protection. We further report that APC induces PAR 1 phosphorylation and desensitizes endothelial cells to thrombin signaling but promotes limited receptor cleavage and negligible internalization and degradation even after prolonged APC exposure. Thus, APC selective signaling and endothelial barrier protective effects are mediated through compartmentalization of PAR 1 in caveolae and a novel mechanism of PAR1 signal regulation.
T
he coagulant protease thrombin is generated in response to vascular injury and in thrombotic disease and drives fibrin deposition and platelet activation, which are critical for hemostasis and thrombosis (1) . Thrombin also promotes proinflammatory responses and disrupts endothelial barrier permeability (2) . Protease-activated receptor-1 (PAR 1 ), a G-protein-coupled receptor (GPCR), is the predominant mediator of thrombin responses in cells. Thrombin activates PAR 1 by cleaving the N-terminal domain, generating a new N terminus that binds intramolecularly to the receptor to trigger transmembrane signaling (3) . Synthetic peptides that represent the newly formed N terminus of PAR 1 can activate the receptor independent of thrombin and proteolytic cleavage. Interestingly, thrombin and peptide agonists differ in their capacity to promote endothelial barrier permeability and Ca 2ϩ mobilization (4) . These studies suggest that distinct cellular responses can be evoked by the same receptor when activated proteolytically by the tethered ligand versus untethered ''free'' synthetic peptide agonists. Similar phenomena have been reported for other GPCRs activated by different ligands and is a poorly understood process termed functional selectivity or biased agonism (5) .
Activated protein C (APC), an anti-coagulant protease, displays cytoprotective and anti-inflammatory activities and has been shown clinically to reduce mortality of patients with severe sepsis (6) . APC is generated on the endothelial cell surface via activation of protein C (PC) by the thrombin-thrombomodulin complex (7) . APC bound to endothelial protein C receptor (EPCR) cleaves and inactivates factors Va and VIIa diminishing thrombin generation and induces cellular responses through the activation of PAR 1 (8, 9) . In contrast to thrombin, however, APC elicits anti-inflammatory responses and promotes endothelial barrier stabilization (10, 11) . The mechanism by which APC exerts anti-inflammatory and cytoprotective signaling in endothelial cells is not fully understood.
Previous studies suggest that most endogenous PC is bound to EPCR on the endothelial cell surface and cleaved by the thrombin-thrombomodulin complex (12) . The newly formed APC is then poised to signal via direct activation of PAR 1 . Thus, APC generation on the endothelial cell surface is linked mechanistically to PAR 1 protective signaling. The cytoprotective and anti-inflammatory responses induced by APC also require the co-factor function of EPCR (9, 13) . Interestingly, thrombomodulin, EPCR and PAR 1 partition into lipid rafts and co-fractionate with caveolin-1, a structural protein essential for caveolae formation in endothelial cells (14) , suggesting that these proteins reside at least partially in caveolar microdomains, a subtype of lipid rafts (15, 16) . However, whether caveolae are required for APC activation of PAR 1 signaling and endothelial barrier protective effects is not known.
Our studies here reveal a critical role for caveolae in APC, but not thrombin, activation of PAR 1 signaling and endothelial barrier protection. These findings demonstrate an essential role for caveolae in agonist selective signaling by PAR 1 . We further show that APC promotes protective effects in endothelial cells by desensitizing cells to thrombin signaling. Remarkably, however, APC causes limited PAR 1 cleavage and negligible internalization and degradation, suggesting a novel mechanism for regulation of PAR 1 signaling.
Results
To determine whether PAR 1 is essential for protease-selective signaling, we examined thrombin and APC signaling in human endothelial cells stably expressing a PAR 1 -specific shRNA (17) . Endothelial cells expressing PAR 1 shRNA displayed minimal PAR 1 expression and signaling, whereas PAR 2 signaling remained intact [supporting information (SI) Fig. S1 ], indicating loss of functional PAR 1 . In control cells, thrombin and APC induced a similar biphasic increase in extracellular signalregulated kinase 1/2 (ERK1/2) activity (Fig. S2 A) . However, cells lacking PAR 1 displayed minimal ERK1/2 activation in response to various concentrations of thrombin or APC compared with control cells (Fig. 1, S3 , and S4). Thrombin-stimulated p38 MAP kinase activation was also lost in cells deficient in PAR 1 expression (Fig. S2C) . In contrast to thrombin, APC failed to stimulate p38 MAP kinase signaling in either control or PAR 1 -deficient cells (Fig. S2B) . These findings suggest that PAR 1 , and not another receptor or factor, is critical for thrombin and APC signaling in endothelial cells.
We next examined endothelial barrier permeability. Thrombin-stimulated endothelial barrier permeability was blocked in cells preincubated with APC ( Fig. 2A) . These findings are consistent with a role for APC in stabilization of endothelial cell-cell junctions and protection against endothelial barrier dysfunction induced by thrombin (10) . We also evaluated the effect of thrombin and APC on the activation of endogenous RhoA and Rac1. Activation of RhoA promotes endothelial barrier dysfunction, whereas Rac1 signaling has been implicated in endothelial barrier stabilization (2) . Thrombin induced RhoA activation but not Rac1 signaling (Figs. 2B and 2C ). In contrast, APC stimulated Rac1 activation and minimal RhoA signaling (Figs. 2B and 2C). Thus, thrombin and APC have the capacity to elicit distinct signaling pathways and to differentially regulate endothelial barrier permeability. Moreover, APC-stimulated increase in Rac1 activation was lost in endothelial cells deficient in PAR 1 expression (Fig. 2D ). These studies demonstrate that endogenous PAR 1 is essential for APC signaling and raise the question of how activation of the same receptor by two different proteases elicits distinct signaling responses in endothelial cells.
PAR 1 and EPCR localize to lipid rafts and associate with caveolin-1 (15), but whether caveolae are essential for APC signaling and endothelial barrier protection has not been determined. To examine the role of caveolae in thrombin and APC signaling, we generated endothelial cells stably expressing a caveolin-1 shRNA to ablate caveolin-1 expression (Fig. 3A) (18) . Importantly, the amount of cell surface PAR 1 and EPCR was similar in control and caveolin-1-lacking cells (Fig. S5 ), suggesting that caveolae deficiency does not globally disrupt protein expression at the cell surface. Interestingly, thrombin activation of ERK1/2 was comparable in control and caveolin-1-deficient endothelial cells (Figs. 3B and S6), indicating that caveolae are not essential for thrombin signaling. Remarkably, however, activation of ERK1/2 by APC was lost in caveolin-1-deficient endothelial cells examined at early and late times (Figs. 3C, S6, and S7). These findings suggest that caveolae are critical for activation of PAR 1 signaling by APC but not thrombin.
We next investigated the function of caveolae in APC-induced Rac1 activation and endothelial barrier protection. APC stimulated a marked increase in Rac1 activation in control cells that was virtually abolished in endothelial cells lacking caveolin-1 (Fig. 4A ). These findings provide further evidence that caveolae are essential for APC activation of PAR 1 signaling. Moreover, APC pretreatment failed to protect caveolin-1-deficient endothelial cells from thrombin-induced endothelial barrier permeability (Fig. 4B) , consistent with loss of APC signaling in caveolin-1-defective cells. Thus, the compartmentalization of PAR 1 in caveolae is essential for APC activation of PAR 1 protective signaling in endothelial cells.
To determine how APC prevents thrombin from causing endothelial barrier dysfunction, we examined whether APC desensitizes cells to thrombin signaling. Thrombin caused robust ERK1/2 activation in naïve cells (Fig. 5A) . By contrast, thrombin-stimulated ERK1/2 activation was markedly reduced in cells pretreated with APC (Fig. 5A) . Interestingly, inhibition of thrombin-induced ERK1/2 activation by APC required caveolin-1 expression (Fig. 5B) , consistent with a critical role for caveolae in APC signaling. Moreover, thrombin-induced RhoA activation and p38 kinase activation were considerably attenuated in cells pretreated with APC (Figs. 5C and S8), providing further evidence that APC desensitizes cells to thrombin signaling to promote endothelial barrier protection. Signaling by PAR 2 agonist peptide, and UTP, an agonist for endogenous purinergic receptors, was unperturbed by APC pretreatment, indicating that endothelial cells are generally responsive to GPCR activation after APC pretreatment (data not shown).
Agonist-induced PAR 1 phosphorylation initiates receptor desensitization (19, 20) . Thus, we determined whether APC promotes phosphorylation of endogenous PAR 1 in endothelial cells. Phosphorylated PAR 1 was detected after thrombin incubation and migrated as a broad band at Ϸ64 kDa (Fig. 6A) (21) . Cells exposed to APC also showed an increase in PAR 1 phosphorylation, which was detected as multiple high-molecular-weight species migrating at and above Ϸ64 kDa (Fig. 6A) . Strikingly, in APC-pretreated cells, thrombin and APC failed to induce phosphorylation of PAR 1 (Fig. 6A) . These data suggest the APC Fig. 1 . PAR 1 is essential for thrombin and APC signaling in endothelial cells. (A and B) Serum-deprived control and PAR 1 shRNA-expressing EA.hy926 endothelial cells were incubated with thrombin or APC (0.5 U/ml hirudin) for 5 minutes at 37°C. ERK1/2 activity was determined by immunoblotting and quantitated as described in Fig. S3 . Data are representative of three independent experiments. regulates thrombin signaling at the level of the receptor to promote endothelial barrier protection.
In addition to phosphorylation, receptor internalization and lysosomal degradation also regulate PAR 1 signaling (22) . We therefore examined whether APC effects PAR 1 trafficking. Thrombin induced rapid and robust PAR 1 internalization (Fig.  6C) . In contrast, APC failed to promote PAR 1 internalization even at high concentrations (Fig. 6C) , consistent with retention of PAR 1 on the cell surface (23) . Remarkably, however, thrombin stimulated comparable increases in PAR 1 internalization in both untreated and APC treated cells (Fig. 6D) , suggesting that APC exposure does not prevent thrombin-induced PAR 1 internalization.
We further investigated whether thrombin promotes PAR 1 degradation in cells exposed to APC. Thrombin caused a shift in mobility and a significant loss of PAR 1 protein in control cells (Fig. 6B) , consistent with thrombin cleavage and degradation of activated PAR 1 . Activation of PAR 1 with the peptide agonist TFLLRNPDNK also decreased receptor protein without altering receptor mobility, as expected (Fig. 6B) . To our surprise, prolonged exposure to APC failed to induce a significant change in PAR 1 mobility or amount of receptor protein detected compared to control cells (Fig. 6B) . Moreover, the extent of PAR 1 degradation induced by thrombin and peptide agonist was comparable in APC-treated and untreated cells (Fig. 6B ). Together these studies suggest that APC desensitizes cells to thrombin signaling by inducing PAR 1 phosphorylation, but causes limited receptor cleavage and negligible internalization and degradation.
Discussion
In the present study, we define a novel function for caveolae in protease-selective signaling by PAR 1 . We show that endogenous PAR 1 is required for thrombin and APC signaling in endothelial cells. We further demonstrate that caveolin-1 is essential for activation of PAR 1 signaling by APC but not thrombin, indicating that caveolae are critical for protease-selective signaling by PAR 1 . Caveolae are also required for activation of PAR 2 by tissue factor-factor VIIa but not the synthetic peptide agonist in transformed cells (24) , consistent with a role for caveolae in protease-selective signaling. Moreover, a function for lipid rafts but not caveolae, in thrombin-induced cytoskeletal changes in endothelial cells has previously been reported (25) . The cytoprotective and endothelial barrier protective effects of APC are also disrupted by methyl-␤-cyclodextrin, a cholesterol-chelating agent, indicating a role for lipid rafts (16) . However, the function of caveolae, a subtype of lipid rafts, in the regulation of APC signaling has not been previously examined. Our studies suggest that APC promotes protective effects by desensitizing endothelial cells to thrombin signaling. We found that APC stimulates PAR 1 phosphorylation and inhibits thrombin signaling but causes limited receptor cleavage, and negligible internalization and degradation. Together these findings suggest that APCmediated endothelial protective signaling requires compartmentalization of PAR 1 in caveolae and a novel mechanism of PAR 1 desensitization to control receptor signaling.
The molecular mechanism by which APC distinctly activates PAR 1 signaling remains unclear. PAR 1 is essential for APC signaling, but whether APC induces an active PAR 1 conformation similar to thrombin is not known. Previous studies have shown that APC has the capacity to cleave PAR 1 , albeit with considerably less efficiency than thrombin (9, 26) . However, whether APC cleavage of PAR 1 is the only critical determinant that facilitates PAR 1 activation of barrier protective signaling is not known. Thrombin cleaves the majority of PAR 1 , causing a shift in receptor mobility and induces receptor degradation, whereas the peptide agonist TFLLRNPNDK promotes PAR 1 degradation but not cleavage and hence does not alter receptor mobility (Fig. 6) . We show here that APC induces PAR 1 signaling and phosphorylation but causes a minimal change in receptor mobility. However, signaling by catalytically inactive APC is markedly inhibited compared to fully active APC (Fig.  S9) , suggesting that activation of PAR 1 by APC requires proteolytic activity. Interestingly, we also show that prolonged APC incubation does not prevent thrombin-induced PAR 1 cleavage, internalization, or degradation. Thus, in endothelial cells exposed to APC, the majority of PAR 1 is retained on the cell surface and susceptible to thrombin cleavage. Our findings raise the intriguing possibility that APC activates a subpopulation of PAR 1 compartmentalized in caveolae and stabilizes an active receptor conformation that may be distinct from noncaveolar localized activated PAR1. How can activation of the same receptor by two different proteases elicit distinct cellular responses? If APC activates PAR 1 through cleavage and unmasking of the tethered ligand like thrombin a similar active receptor conformation would be induced. However, the extent of PAR 1 activation by APC would be different from thrombin, which efficiently cleaves the receptor (26) . In this case, we would expect to observe quantitative, not qualitative, differences in signaling. Thrombin-activated PAR 1 couples to G␣ q , G␣ 12/13 , and RhoA signaling, which induces endothelial barrier dysfunction (2) . In contrast, we show that APC-activated PAR 1 stimulates Rac1, but not RhoA, signaling and promotes endothelial barrier protection. Thus, the activation of PAR 1 by APC may result in a distinct active receptor conformation that selectively couples to different signaling pathways. We further show that caveolin-1 is essential for APC but not thrombin activation of PAR 1 signaling and endothelial barrier protective effects, suggesting that PAR 1 localization to caveolae is critical for protease-selective signaling. Previous studies have shown that the APC co-factor EPCR, PAR 1 , G␣ q and G␣ i partition into lipid rafts and interact with caveolin-1 (15, 16, 27) . The barrier protective signaling induced by APC is also blocked by pertussis toxin, suggesting a role for G␣ i/o proteins in this process (15) . Moreover, the binding of APC to EPCR facilitates efficient PAR 1 cleavage in lipid rafts and endothelial barrier signaling, suggesting that caveolae localization may induce a distinct active receptor conformation that elicits barrier protective signaling (28) . Thus, PAR 1 , EPCR, and G␣ i/o proteins localize to caveolae and may exist as a preassembled complex poised to signal after PC binding to EPCR and generation of APC. In contrast, caveolin-1 is not essential for thrombin activation of PAR 1 signaling (Figs. 3 and 4) , indicating that caveolin-1 modulates PAR 1 signaling only when selectively activated by APC and not by thrombin in endothelial cells.
Our studies provide new insight into the molecular mechanisms responsible for protease-selective signaling by PAR 1 . ]orthophosphate were preincubated with or without 10 nM APC for 3 hours at 37°C and then stimulated with 10 nM Th or 10 nM APC for 3 minutes at 37°C. Immunoprecipitated 32 P-labeled PAR1 was detected as described (21) . Similar results were observed in three independent experiments. (B) Cells pretreated with or without 10 nM APC for 3 hours at 37°C, and then incubated with 10 nM thrombin (Th), 10 nM APC, or 100 M TFLLRNPNDK for 90 minutes at 37°C and the amount of PAR1 was determined as described (21) . Asterisk indicates detection of the heavy and light chains of the immunoprecipitating antibodies. Data (mean Ϯ SE) are expressed as the fraction of PAR 1 protein remaining compared with untreated control and are the averages of three independent experiments. A significant difference (* P Ͻ 0.05 or ** P Ͻ 0.01) was detected between agonist-treated versus untreated controls in some cases. (C) Cells were incubated in the absence or presence of thrombin (Th) or APC for various times at 37°C and the amount of PAR 1 remaining on the cell surface was quantitated by enzyme-linked immunosorbent assay (ELISA). Data (mean Ϯ SD, n ϭ 3) are representative of three independent experiments. The difference between thrombin and untreated control at various times was significant (* P Ͻ 0.05). (D) Cells were preincubated with or without 10 nM APC for 3 hours at 37°C, washed, and then treated with or without 10 nM thrombin (Th) for various times at 37°C. Cells were fixed and processed, and the amount of PAR 1 remaining on the cell surface was measured by ELISA. Data (mean Ϯ SD, n ϭ 3) are from one representative experiment.
